• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Trials Support Psilocybin for Transitional Cluster Headache and Migraine Treatment

by
November 17, 2026
in Health
Reading Time: 2 mins read
0
Trials Support Psilocybin for Transitional Cluster Headache and Migraine Treatment

Trials Support Psilocybin for Transitional Cluster Headache and Migraine Treatment

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Clinical trials in cluster headache and migraine have supported the reported efficacy and safety of psilocybin in the transitional treatment of these disorders, according to an evidence perspective published in Nature Reviews Neurology. Authors Erik Zorrilla and Emmanuelle A. D. Schindler emphasize that psychedelic compounds are re-emerging as potential therapeutic options across headache medicine, showing particular clinical relevance for cluster headache.

Headache disorders are common neurological conditions with numerous treatment options that vary according to the specific disorder and the distinct needs of each individual. The authors observe that the renewed scientific and clinical interest in psychedelic treatments for headache is largely attributable to the patient community, whose members have consistently advocated for their preferred forms of management, including psychedelic medications.

In addition to psilocybin, compounds such as dimethyltryptamine and lysergic acid diethylamide have played important historical roles in headache medicine. The Perspective reviews this historical context, the documented chronology of major events linking psychedelics to headache care, and the proposed mechanisms of action for these agents. The authors also evaluate how psychedelics relate to conventional headache medications, observing that further studies investigating other compounds and modes of treatment are already ongoing or on the horizon.

Despite these developments, the authors stress that the clinical and scientific evidence available to date remains limited in scope. Significant safety, logistical, and legal concerns also surround the use of psychedelic compounds, requiring careful evaluation to resolve existing challenges and set the stage for rigorous future work in the field of headache medicine.

Subject of Research: Psychedelic drug therapies in headache medicine

Article Title: Psychedelic treatment for headache disorders

Article References: Zorrilla, E., & Schindler, E. A. D. (2026). Psychedelic treatment for headache disorders. Nature Reviews Neurology. https://doi.org/10.1038/s41582-026-01285-w

Image Credits: AI Generated

DOI: 10.1038/s41582-026-01285-w

Keywords: headache disorders, psilocybin, cluster headache, migraine, dimethyltryptamine, lysergic acid diethylamide, psychedelic medicine, transitional treatment, clinical trials, neurology, patient advocacy, mechanisms of action, conventional headache medications, headache chronology, drug safety, treatment efficacy

News Source: Ophelia Keating. (November 17, 2026). Trials Support Psilocybin for Transitional Cluster Headache and Migraine Treatment. Scienmag.

Tags: Clinical Trialscluster headacheconventional headache medicationsdimethyltryptaminedrug safetyheadache chronologyheadache disorderslysergic acid diethylamidemechanisms of actionmigraineneurologypatient advocacypsilocybinpsychedelic medicinetransitional treatmentTreatment efficacy
Share12Tweet7Share2ShareShareShare1

Related Posts

Heart Failure Linked to Reduced Immunotherapy Toxicity in Lung Cancer Study

Heart Failure Linked to Reduced Immunotherapy Toxicity in Lung Cancer Study

November 20, 2026
Arabic Validation of Reproductive Autonomy Scale Shows High Repeatability in Egypt

Arabic Validation of Reproductive Autonomy Scale Shows High Repeatability in Egypt

November 20, 2026

Hip Replacement and Lumbar Spine Fusion Order Does Not Alter Complication Risks

November 20, 2026

Dubai Survey Links Individualism and Self-Efficacy to Higher Physical Activity Levels

November 20, 2026

POPULAR NEWS

  • Transient Neonatal Diabetes Can Signal Rare HNF1B Whole-Gene Deletions

    Transient Neonatal Diabetes Can Signal Rare HNF1B Whole-Gene Deletions

    29 shares
    Share 12 Tweet 7
  • Vernacular Names Reveal Ethnobotanical Plant Exudate Knowledge in Brazil

    29 shares
    Share 12 Tweet 7
  • Nurses in 2023 Turkey Mission Faced Emotional Strains and Operational Hurdles

    29 shares
    Share 12 Tweet 7
  • Arabic Resilience and Relapse Scales Show High Reliability in Emirati Addiction Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Flipped BIM Course Leaves Saudi Engineering Cognitive Test Scores Unchanged

Heart Failure Linked to Reduced Immunotherapy Toxicity in Lung Cancer Study

Arabic Validation of Reproductive Autonomy Scale Shows High Repeatability in Egypt

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.